ASSESSING THE EFFECTIVENESS OF A NEW ANTI-DIABETIC FORMULATION (DIAKURE)

Phase 1/2

Not yet recruiting

• Conditions: DIABETIC

• Registration Number: CTRI/2015/06/005891
• Lead Sponsor: RVS COLLEGE OF PHARMACEUTICAL SCIENCES

Brief Summary

**Chander et al., A Study of Pharmaceutical Care Impact on Cardiovascular Risk in Diabetic and Hypertensive Patients: IJPSR, 2013;vol 4 (8): 3235-3141**

Detailed Description

Not available

Study Timeline

• Study Start: 2015-01-07
• Last Update Posted: 2015-05-06

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Patients diagnosed with type 2 diabetes mellitus.
• Patient who are keeping up their regular follow-up visits.
• Patients who are competent enough to consider informed consent.

Exclusion Criteria

• Patients who are very frail.
• Patients in their gestational and lactating period.
• Patients diagnosed with cardiac and psychiatric disorders.
• Patients above and below the age group.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood sugar levels (both random and fasting)	Once in 15 days.

Secondary Outcome Measures

Name	Time	Method
Glycosylated Hemoglobin (HbA1c)	BMI

Trial Locations

Locations (1)

AYURVEDA HOSPITAL COIMBATORE; 🇮🇳 Coimbatore, TAMIL NADU, India

AYURVEDA HOSPITAL COIMBATORE

🇮🇳Coimbatore, TAMIL NADU, India

SHAWN TOMY

Principal investigator

9952164122

shawn.kandathil1@gmail.com